Payer PolicyActive
Bronchial Thermoplasty – Commercial and Individual Exchange Medical Policyopen_in_new
UHC-POL-bronchial-thermoplasty
UnitedHealthcare
Effective: October 1, 2025
Updated: December 6, 2025
created · Nov 30, 2025
Policy Summary
UnitedHealthcare considers bronchial thermoplasty unproven and not medically necessary for treating asthma and lists no covered indications. Professional guidance cited requires BT to be performed only in IRB‑approved clinical trials or registries (and, per NICE, in specialist centers with appropriate support), notes exclusions such as chronic sinus disease, frequent chest infections, or FEV1 <60% predicted, and coverage decisions must follow the member‑specific benefit plan.
Coverage Criteria Preview
Key requirements from the full policy
"None — "Bronchial thermoplasty is unproven and not medically necessary for treating asthma due to insufficient evidence of efficacy."
Sign up to see full coverage criteria, indications, and limitations.